Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

485.04 +4.71 (+0.98%)
Streaming Delayed Price Updated: 11:58 AM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
57 58 Next >
Which Stocks Pass Warren Buffett's $10,000 Test?
Buffett's recent CNBC interview raises an interesting question. 
Via The Motley Fool
Prediction: These Will Be 3 of the Biggest Monster Stocks of the Decade
They're already highly successful. But there's a lot more room to run. 
Via The Motley Fool
Is CRISPR Therapeutics Stock a Buy Now?
The biotech could soon be a commercial-stage company. 
Via The Motley Fool
Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today?
While CRSPR stock captured the spotlight for potentially encouraging drug data, the news lifted other gene-editing stocks. 
Via InvestorPlace
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) Records 52-Week High Thursday Morning
Via Investor Brand Network
$2M Price Tag for Sickle Cell Gene Therapies Could Be Cost-Effective Under Certain Scenarios, Finds ICER Analysis
Via Benzinga
CRISPR Stock: Bull vs. Bear
CRISPR's first approved product may be right around the corner. 
Via The Motley Fool
2 Nasdaq Growth Stocks That Are Screaming Buys in April
Massive drivers of fresh earnings are drawing closer, and risks are declining. 
Via The Motley Fool
Moderna, ConocoPhillips, Vertex Pharmaceuticals And This ETF: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Anastasia Amoroso of JP Morgan Private Bank named iShares Preferred and Income Securities ETF (NYSE: PFF) as her 
Via Benzinga
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) Sets New 52-Week High in Wednesday Session
Via Investor Brand Network
Could This Move Make Vertex's Next Blockbuster Even Bigger?
Vertex is showing it can branch out beyond its cystic fibrosis specialty. 
Via The Motley Fool
Vertex to Announce First Quarter 2023 Financial Results on May 1
From Vertex Pharmaceuticals Incorporated
Via Business Wire
My 5 Top Stocks to Buy in April
These stocks share one primary common denominator -- great growth prospects. 
Via The Motley Fool
2 Winning Stocks That Could Turn $10,000 into $50,000 by 2030
These stocks have growth stories that could supercharge returns over the long run. 
Via The Motley Fool
3 No-Brainer Stocks to Buy in a New Bull Market
These stocks have what it takes to soar if and when a new bull market begins. 
Via The Motley Fool
Nasdaq Bear Market: 5 Astonishing Growth Stocks You'll Regret Not Buying on the Dip
A 33% plunge in the Nasdaq Composite is the perfect excuse for opportunistic investors to pounce on discounted growth stocks. 
Via The Motley Fool
5 S&P 500 Stocks Showing Strength As Recession Fears Rise
Medical stocks are holding up amid economic and market uncertainty. 
Via Investor's Business Daily
2 Once-in-a-Decade Buying Opportunities in a Growth Stock Bear Market
These stocks have growth stories that investors might find too compelling to overlook. 
Via The Motley Fool
A Bull Market Is Coming: 2 Unstoppable Growth Stocks to Scoop Up Right Now
Don't let these superior stocks pass you by. 
Via The Motley Fool
2 Smartest Growth Stocks to Buy Without Hesitation Right Now
A turbulent market is still full of opportunity for shrewd investors. 
Via The Motley Fool
Where to Invest $2,500 Right Now
Even another bear market doesn't need to deter investors with the appropriate buy-and-hold horizon. 
Via The Motley Fool
2 Top Stocks to Buy Before the Next Nasdaq Bull Market
Tough market conditions will eventually give way to the next bull run on stocks. 
Via The Motley Fool
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global
Via Benzinga
Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy?
Vertex shares are on the rise. 
Via The Motley Fool
Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags
It was very difficult to make money in Q1 trading healthcare or biotech ETFs because of the sharp rally in other sectors. Nonetheless, there were two big winners. 
Via Talk Markets
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 5 Years
Via Benzinga
Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
From Vertex Pharmaceuticals Incorporated
Via Business Wire
A Nasdaq Bull Market Could Begin in April: 3 Top Stocks to Buy Now
The momentum for these stocks should accelerate when a Nasdaq bull market begins. 
Via The Motley Fool
5 Top Stocks for April
From growth stocks to dividend stocks, there are plenty of buying opportunities this spring. 
Via The Motley Fool
The 10 Best Stocks to Buy in April 2023
Here are 10 stocks to buy now that could unlock explosive gains in your growth-stock portfolio. 
Via The Motley Fool
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
57 58 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.